交易中 10-06 10:14:12 美东时间
-1.440
-1.72%
https://www.axios.com/2026/09/30/hhs-clinical-trials-redesign
10-01 03:17
2026 年 9 月 22 日,美国政府道德办公室(OGE)公开特朗普最新一期定期交易报告。 文件共 37 页,记录了其投资账户今年 7 月的 115...
09-23 21:43
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
07-25 20:00
Quest Diagnostics (NYSE: DGX) stock jumps after Q2 earnings beat estimates and full-year 2026 guidance gets a boost.
07-24 01:47
Tempus AI acquires Personalis for $1.5B to target the $20B MRD cancer monitoring market. Get full deal details and analysis.
07-22 02:52
Growth and chip stocks led a mixed Wall Street tape Monday as the S&P 500 and Nasdaq 100 rose while the Dow and small caps slipped.
07-21 01:42
Tempus AI stock falls after a $1.5 billion Personalis deal expands its reach in the $20 billion MRD market.
07-21 00:46
Bristol Myers Squibb adopts NVIDIA DGX SuperPOD to train next-gen AI models and accelerate drug discovery.
07-20 22:05
ARKK ETF, the flagsfhip fund for Cathie Wood's company, is losing assets as investors dump after years of underperformance.
07-19 04:36
Lucid, Figma, SoundHound and Ondas are among the most heavily shorted stocks in the market right now.
07-14 02:29